FDA Panel Rejects Steroid-Sparing Claim For Remicade In Pediatric Ulcerative Colitis
This article was originally published in The Pink Sheet Daily
Executive Summary
Extrapolation from adult data does not work in this case and there is insufficient supporting pediatric data, the Gastrointestinal Drugs Advisory Committee concluded July 21.